Krystal Biotech, Inc. (KRYS) stock
KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 11/3052% above fair value
$315.34+16.79 (+5.62%)
Close on Nov 18, 2026Market cap $9.33BP/E 39.5Yield –
Krystal Biotech market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Krystal Biotech's market cap was $9.14B on Nov 11, 2026, against $6.32B a year earlier. Over the last 5 years it ranged from $1.31B to $10.94B, with a median of $4.45B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.14B | +27.9% |
| 2025 | Dec 31, 2025 | $7.15B | +58.6% |
| 2024 | Dec 31, 2024 | $4.51B | +28.8% |
| 2023 | Dec 29, 2023 | $3.50B | +71.7% |
| 2022 | Dec 30, 2022 | $2.04B | +30.9% |
| 2021 | Dec 31, 2021 | $1.56B | +31.6% |
| 2020 | Dec 31, 2020 | $1.18B | +23.4% |
| 2019 | Dec 31, 2019 | $958.50M | +320.1% |
| 2018 | Dec 31, 2018 | $228.14M | +111.8% |
| 2017 | Dec 29, 2017 | $107.70M | – |
See a number that looks wrong?